AGARWALA SANDIP purchased 7.9% of their position (235K shares) of TOURMALINE BIO, INC. on the open market
Open‑market purchase worth $4.00M — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/11/2021ACC: 0000899243-21-019167
Director10% Owner
Since May 2021
+235K
Net shares
Net buyer
$4.00M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
3.22M acquired · 2.99M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+2.99M
Price / share
—
Trade value
—
% of position
New position
5/11/2021
0.00→2.99M
Common Stock
Indirect
Shares
+235K
Price / share
$17.00
Trade value
$4M
% of position
7.9%
5/11/2021
2.99M→3.22M
Total
Net shares
+3.22M
Net value
$4M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/11/2021 | C · Conversion | +2.99M | — | — | New position | 0.00 | 2.99M |
| Common Stock Indirect | 5/11/2021 | P · Purchase | +235K | $17.00 | $4M | 7.9% | 2.99M | 3.22M |
| Total | +3.22M | $4M | ||||||
Derivative Transactions3
Series A Preferred Stock
Indirect
Converts to
Common Stock
1.31M shares
Shares
−1.31M
Strike price
Held after
0.00
Exercisable
—
5/11/2021
Series A-1 Preferred Stock
Indirect
Converts to
Common Stock
1.27M shares
Shares
−1.27M
Strike price
Held after
0.00
Exercisable
—
5/11/2021
Series B Preferred Stock
Indirect
Converts to
Common Stock
406.34K shares
Shares
−406.34K
Strike price
Held after
0.00
Exercisable
—
5/11/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock1.31M shares | 5/11/2021 | C · Conversion | −1.31M | — | 0.00 | |
| Series A-1 Preferred Stock Indirect | Common Stock1.27M shares | 5/11/2021 | C · Conversion | −1.27M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock406.34K shares | 5/11/2021 | C · Conversion | −406.34K | — | 0.00 |